MEDICLINIC INTERNATIONAL PLC - Notification of Major Interest in Mediclinic International plc shares

Release Date: 29/01/2019 16:30
Code(s): MEI
 
Wrap Text
Notification of Major Interest in Mediclinic International plc shares

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic”, the “Company” or the “Group”)

29 January 2019

Notification of Major Interest in Mediclinic International plc shares

1a. Identity of the issuer or the underlying issuer                                           Mediclinic International plc.
of existing shares to which voting rights are at-
tached:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights                                                                             X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:

3. Details of person subject to the notification obligation
Name                                                           Coronation Asset Management (Pty) Ltd acting as dis-
                                                               cretionary investment manager on behalf of managed
                                                               portfolios.
City and country of registered office (if applicable)          Cape Town, South Africa

4. Full name of shareholder(s) (if different from 3.)v
Name                                                           N/A
City and country of registered office (if applicable)

5. Date on which the threshold was crossed or                  29/01/2019
reached:

6. Date on which issuer notified (DD/MM/YYYY):                 29/01/2019

7. Total positions of person(s) subject to the notification obligation

                          % of voting rights at-   % of voting rights          Total of both in %      Total number of
                          tached to shares (to-    through financial instru-   (8.A + 8.B)             voting rights of is-
                          tal of 8. A)             ments                                               suer
                                                   (total of 8.B 1 + 8.B 2)
                                                                                                                      
Resulting situation       2.82                                                 2.82                    737 243 810
on the date on which
threshold was
crossed or reached
Position of previous      3.98                                                 3.98
notification (if
applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or
reached

A: Voting rights attached to shares

Class/type of             Number of voting rights                          % of voting rights
shares
ISIN code (if possible)   Direct                  Indirect                 Direct                     Indirect
                          (Art 9 of Directive     (Art 10 of Directive     (Art 9 of Directive        (Art 10 of Directive
                          2004/109/EC) (DTR5.1)   2004/109/EC)             2004/109/EC) (DTR5.1)      2004/109/EC)
                                                  (DTR5.2.1)                                          (DTR5.2.1)
GB00B8HX8Z88              20 825 908                                       2.82

SUBTOTAL 8. A             20 825 908                                       2.82

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial in-     Expiration     Exercise/                       Number of voting rights      % of voting rights
strument                  date           Conversion Period               that may be acquired if
                                                                         the instrument is
                                                                         exercised/converted.

                                         SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
Type of financial    Expiration          Exercise/               Physical or          Number of       % of voting rights
instrument           date                Conversion Pe-          cash                 voting rights
                                         riod                    settlement

                                                                 SUBTOTAL
                                                                 8.B.2
                                                                                                                       
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity xiv       X
(please add additional rows as necessary)
                                                                       
Name                                         % of voting rights        % of voting rights          Total of both if it
                                             if it equals or is        through financial           equals or is higher
                                             higher than the           instruments if it           than the notifiable 
                                             notifiable thresh-        equals or is higher         threshold                                   
                                             old                       than the notifiable         
                                                                       threshold                                                                                                                              
Coronation Fund Managers Ltd                                      
Coronation Investment Management
SA (Pty) Ltd
Coronation Asset Management (Pty)
Ltd                                          2.82                                                  2.82

10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held

11. Additional information

Place of completion          Cape Town, South Africa
Date of completion           29/01/2019

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the
JSE in South Africa and the NSX in Namibia.

For further information, please contact:
                                                                                                                         
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 29/01/2019 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story